Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

43.9K
Overview
43.9K
Influenza01:27

Influenza

79
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
79
Development of Immunocompetence01:22

Development of Immunocompetence

1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Vaccines01:21

Vaccines

86
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
86
Vaccine Production01:23

Vaccine Production

129
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
129
Immunological Memory01:23

Immunological Memory

12.3K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
12.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-stratified transmission model of COVID-19 in Ontario with human mobility during pandemic's first wave.

Heliyon·2021
Same author

Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.

Vaccine·2020
Same author

Detecting and distinguishing tipping points using spectral early warning signals.

Journal of the Royal Society, Interface·2020
Same author

Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults.

Journal of medical microbiology·2019
Same author

Adoption costs of new vaccines - A Stackelberg dynamic game with risk-perception transition states.

Infectious Disease Modelling·2019
Same author

Homophilic replicator equations.

Journal of mathematical biology·2016

Related Experiment Video

Updated: Apr 27, 2026

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.6K

Examining Ontario's universal influenza immunization program with a multi-strain dynamic model.

E W Thommes1, A Chit2, G C Meier3

  • 1Medical Division, GlaxoSmithKline Inc., 7333 Mississauga Road, Mississauga, ON, Canada L5N 6L4; Department of Mathematics & Statistics, University of Guelph, 50 Stone Road East, Guelph, ON, Canada N1G 2W1.

Vaccine
|July 16, 2014
PubMed
Summary
This summary is machine-generated.

A new dynamic transmission model shows that Ontario's universal influenza immunization program (UIIP) halved influenza-associated health outcomes. This mathematical model tracks four dominant seasonal influenza strains, aiding future public health strategies.

Keywords:
CanadaDynamic transmission modelInfluenzaOntarioTIVUniversal vaccination

More Related Videos

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
13:12

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Published on: April 4, 2011

17.6K
An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

36.1K

Related Experiment Videos

Last Updated: Apr 27, 2026

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.6K
Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
13:12

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Published on: April 4, 2011

17.6K
An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

36.1K

Area of Science:

  • Epidemiology
  • Mathematical Modeling
  • Public Health

Background:

  • Seasonal influenza presents a substantial global health challenge annually.
  • Mathematical models are crucial for evaluating vaccination strategies' impact on disease burden.
  • Understanding influenza transmission dynamics is key to effective control measures.

Purpose of the Study:

  • To develop a novel dynamic transmission model for seasonal influenza.
  • To retrospectively assess the impact of Ontario's universal influenza immunization program (UIIP) initiated in 2000.
  • To analyze the reduction in influenza-associated health outcomes following the UIIP implementation.

Main Methods:

  • Development of a dynamic transmission model that explicitly tracks four dominant seasonal influenza strains/lineages.
  • Retrospective analysis of influenza data in Ontario, Canada, post-UIIP implementation.
  • Model calibration and validation against existing epidemiological data.

Main Results:

  • Model simulations indicated approximately a 50% reduction in influenza-associated health outcomes in Ontario in the four seasons following the UIIP.
  • Observed age-specific trends in health outcomes align with previous administrative data studies.
  • The model highlights the significant public health impact of universal influenza vaccination programs.

Conclusions:

  • The universal influenza immunization program in Ontario demonstrated a substantial reduction in influenza-related health outcomes.
  • The developed dynamic transmission model provides a valuable tool for assessing influenza control strategies.
  • The model's flexibility allows for extension to explore various future influenza vaccination scenarios and strain interactions.